The U.S. Drug Enforcement Administration (DEA) has approved the first clinical trial using MDMA along with psychotherapy to treat anxiety among people with life-threatening illnesses, researchers told Al Jazeera on Tuesday, adding that public support for the therapeutic use of psychedelic drugs is rapidly growing. "The tide has changed for psychedelic research," said Brad Burge, communications director of for the Multidisciplinary Association for Psychedelic Studies...
Read more: http://ift.tt/1GpSvpD
No comments:
Post a Comment